Skip to main content
SpringerLink
Log in

LAAC with Watchman device offers cost savings in NVAF

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 British pounds

Reference

  • Panikker S, et al. Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation. European Heart Journal : Mar 2016. Available from: URL: http://doi.org/10.1093/eurheartj/ehw048

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

LAAC with Watchman device offers cost savings in NVAF. PharmacoEcon Outcomes News 749, 21 (2016). https://doi.org/10.1007/s40274-016-2908-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2908-5

Search

Navigation